Y4T-29954-76839
4 vaccinations
11 coded responses
11 check-ins
10 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 750 / TX
- Registered
- 2022-10-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-11-20
Dose 3 — Pfizer-BioNTech
-
2022-10-13
Dose 4 — Pfizer-BioNTech
-
2022-10-14
Registered in v-safe
-
2022-10-14
Survey response — days 1–6 daily, dose 4MedDRA: Injection site warmth — Feeling: Poor · Site: Redness, Swelling · HeadacheFree text: Injection site hot to the touchMedDRA releases: 2024-11 · check-in free text available
-
2022-10-15
Survey response — days 1–6 daily, dose 4MedDRA: Injection site discolouration, Injection site erythema, Injection site vesicles, Skin exfoliation — Feeling: Fair · Site: Pain, Redness · Rash, not including the immediate area around the injection siteFree text: Injection site is less red. Large spot is reducing but has some streaks with red or brown skin. Small raised blister bumps and skin that turned brown comes off like a burn.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain, Skin burning sensation — Feeling: Good · Site: RednessFree text: Skin still burned. Issuing aloe Vera and treating burn from injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Survey response — days 1–6 daily, dose 4MedDRA: Erythema, Scab, Skin burning sensation — Feeling: Good · Site: RednessFree text: Skin still has red mark and and scabs forming over burnt skinMedDRA releases: 2024-11 · check-in free text available
-
2022-10-18
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain, Injection site rash, Injection site scar — Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteFree text: Rash and burn scar around injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain, Injection site rash, Injection site scar — Feeling: Good · Site: Redness · HeadacheFree text: Scar from rash/burned skin at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Survey response — day 7, dose 4MedDRA: Injection site pain, Skin exfoliation — Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteFree text: Skin peeling from burn due to injection.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Survey response — day 14, dose 4MedDRA: Headache — Feeling: FairFree text: Increase in headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-03
Survey response — day 21, dose 4MedDRA: Headache, Injection site pruritus — Feeling: GoodFree text: Headaches and itching at injections siteMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Survey response — day 35, dose 4MedDRA: Respiratory tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Report sent to call center — day 35, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-21
-
2023-01-14
Survey response — 3 months, dose 4MedDRA: Malaise, Thermal burn, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-14
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-17
- 2023-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | No |
| 2 | 2021-03-26 | Pfizer-BioNTech | No |
| 3 | 2021-11-20 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-19 | Unsuccessful | |
| 2023-01-14 | Unsuccessful |
Free text
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Injection site hot to the touch
Systemic reaction (other): Injection site is less red. Large spot is reducing but has some streaks with red or brown skin. Small raised blister bumps and skin that turned brown comes off like a burn.
Systemic reaction (other): Skin still burned. Issuing aloe Vera and treating burn from injection site
Systemic reaction (other): Skin still has red mark and and scabs forming over burnt skin
Systemic reaction (other): Rash and burn scar around injection site
Systemic reaction (other): Scar from rash/burned skin at injection site
Release 12 — day 7, dose 4
Systemic reaction (other): Skin peeling from burn due to injection.
Release 12 — day 14, dose 4
Symptoms: Increase in headaches
Release 12 — day 21, dose 4
Symptoms: Headaches and itching at injections site
Release 12 — day 35, dose 4
Symptoms: Respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Injection site pruritus | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | Thermal burn | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Erythema | · | · | ✓ |
| SRO | Injection site discolouration | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site rash | · | · | ✓ |
| SRO | Injection site scar | · | · | ✓ |
| SRO | Injection site vesicles | · | · | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Scab | · | · | ✓ |
| SRO | Skin burning sensation | · | · | ✓ |
| SRO | Skin exfoliation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release